Clinical Research Center of Reading,LLC
Wyomissing, Pennsylvania, United States
Research institute in the Spring Ridge, Pennsylvania
2760 Century Blvd # 3, Reading, PA 19610
About Clinical Research Center of Reading,LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
15
Eli Lilly and Company
13
Hoffmann-La Roche
7
Bristol-Myers Squibb
4
Kowa Research Europe
4
Cephalon
3
Genentech, Inc.
3
Rigel Pharmaceuticals
3
Amgen
2
Astellas Pharma Inc
2
EMD Serono
2
Clinical Trials at Clinical Research Center of Reading,LLC
During the past decade, Clinical Research Center of Reading,LLC conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 45 clinical trials were completed, i.e. on
average, 225% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 15 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis
2002-03-01
2004-01-01
Completed
210
Trial With HuMax-CD4 in Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate and a TNF-alpha Blocker
2002-09-01
Terminated
75
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
2000-04-27
2003-11-07
Completed
2,532
Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
2005-03-01
2007-05-01
Completed
500
Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee
2003-04-01
2004-06-01
Completed
529
Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)
2006-08-01
2007-12-01
Completed
189
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Clinical Research Center of Reading,LLC" #1 sponsor was "Pfizer" with 15 trials, followed by "Eli Lilly and Company" with 13 trials
sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored and "Cephalon"
with 4 trials sponsored. Other sponsors include 27 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Center of Reading,LLC"
#1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Clinical Research Center of Reading,LLC
According to Clinical.Site data, the most researched conditions in "Clinical Research Center of Reading,LLC" are
"Rheumatoid Arthritis" (27 trials), "Osteoarthritis" (8 trials), "Arthritis, Rheumatoid" (7 trials), "Chronic Pain" (4 trials) and "Lupus Erythematosus, Systemic" (4 trials). Many other conditions were trialed in "Clinical Research Center of Reading,LLC" in a lesser frequency.
Clinical Trials Intervention Types at Clinical Research Center of Reading,LLC
Most popular intervention types in "Clinical Research Center of Reading,LLC" are "Drug" (63 trials), "Biological" (10 trials), "Other" (7 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (31 trials), "Baricitinib" (6 trials), "Methotrexate" (6 trials), "Tocilizumab" (4 trials) and "Abatacept" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Clinical Research Center of Reading,LLC
The vast majority of trials in "Clinical Research Center of Reading,LLC" are
72 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Clinical Research Center of Reading,LLC
Currently, there are NaN active trials in "Clinical Research Center of Reading,LLC".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 64 completed trials in Clinical Research Center of Reading,LLC,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Clinical Research Center of Reading,LLC, 2 "Phase 1"
clinical trials were conducted, 26 "Phase 2" clinical
trials and 38 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 3 trials that are defined as “Not Applicable".